top of page



ROSE trial - Early Neuromuscular Blockade in ARDS
In ARDS, while following ARMA trial ventilator management, adding paralyzing agents does not improve survival.
Martin Cearras, MD
Oct 12 min read
Â
Â
Â


VASST Trial: Vasopressin use in Septic Shock - subgroup analysis results should not change practice.
VASST trial, showing vasopressin added to levophed does not improve outcomes or have more harm.
Martin Cearras, MD
Sep 70 min read
Â
Â
Â


PROSEVA trial - to prone or not to prone.
Prone positioning in the ICU improves survival in severe ARDS
Martin Cearras, MD
Sep 30 min read
Â
Â
Â
bottom of page